Transthyretin (TTR) variant amyloidosis (ATTRv) is an autosomal dominant disease characterized by the formation and storage of amyloid aggregates in many organs, mostly causing an axonal sensory-motor neuropathy, cardiomyopathy, gastrointestinal dysfunction, and dysautonomia. This evidence concerns the gene TTR and autosomal dominant disease.